Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

The Egyptian Heart Journal

Table 3 Cox-regression analysis on total mortality

	Univariate OR, 95 CI	P	Multivariate OR, 95 CI	P
Cox-regression analysis of comorbid diseases on total mortality
Age	1.07 (1.06–1.08)	< 0.001	1.07 (1.06–1.08)	< 0.001
Gender (female)	0.61 (0.52–0.70)	< 0.001	0.61 (0.52–0.70)	< 0.001
HT	1.93 (1.66–2.24)	< 0.001	0.99 (0.84–1.18)	0.973
DM	1.18 (1.01–1.38)	0.042	1.07 (0.91–1.26	0.369
CAD	1.63 (1.40–1.91)	< 0.001	0.94 (0.79–1.12)	0.537
HF	2.44 (1.95–3.07)	< 0.001	1.36 (1.05–1.76)	0.018
COPD	2.10 (1.77–2.48)	< 0.001	1.25 (1.05–1.49)	0.009
CVE	1.53 (1.03–2.29)	0.034	0.91 (0.61–1.37)	0.676
CRF	2.36 (1.73–3.23)	< 0.001	1.80 (1.31–2.47)	< 0.001
AF	2.52 (2.21–2.87)	< 0.001	1.56 (1.35–1.79)	< 0.001
Cox-regression analysis of comorbid diseases and AF types on total mortality
Age	1.07 (1.06–1.08)	< 0.001	1.07 (1.06–1.08)	< 0.001
Gender (female)	0.61 (0.52–0.70)	< 0.001	0.61 (0.52–0.70)	< 0.001
HT	1.93 (1.66–2.24)	< 0.001	0.99 (0.84–1.18)	0.973
DM	1.18 (1.01–1.38)	0.042	1.07 (0.91–1.26	0.369
CAD	1.63 (1.40–1.91)	< 0.001	0.94 (0.79–1.12)	0.537
HF	2.44 (1.95–3.07)	< 0.001	1.36 (1.05–1.76)	0.018
COPD	2.10 (1.77–2.48)	< 0.001	1.25 (1.05–1.49)	0.009
CVE	1.53 (1.03–2.29)	0.034	0.91 (0.61–1.37)	0.676
CRF	2.36 (1.73–3.23)	< 0.001	1.80 (1.31–2.47)	< 0.001
Pre-existing AF	1.90 (1.48–2.45)	< 0.001	1.08 (0.83–1.43)	0.539
NOAH	6.90 (5.24–9.08)	< 0.001	2.98 (2.24–3.96)	< 0.001

Abbreviations: HT hypertension, DM diabetes mellitus, CAD coronary artery disease, HF heart failure, COPD chronic obstructive pulmonary disease, CVE cerebrovascular event, CRF chronic renal failure, AF atrial fibrillation, NOAF new-onset atrial fibrillation